trypsin-digestion-of-peptides Tumor-targeting peptides represent a significant advancement in the field of cancer treatment, offering a promising new therapeutic approach for selectively delivering therapeutic and diagnostic agents directly to cancerous sites. These short peptide sequences are designed to bind with high affinity to specific molecules or cell surface receptors overexpressed on tumor cells or within the tumor microenvironment. This precise targeting mechanism allows for the delivery of higher doses of chemotherapeutic drugs or diagnostic agents to the tumor while minimizing exposure to healthy tissues, thereby reducing the devastating side effects often associated with conventional cancer therapies.
The efficacy of tumor-targeting peptides lies in their ability to exploit unique characteristics of the tumor2021年8月30日—Numerous peptide-based tumor-imaging agents targeting ssthave been developed over the past decades. Octreoscan® and NeoTect® (technetium-99m- .... These peptides can bind to a variety of targets, including:
* Tumor-specific cell surface receptors: Many cancer cells express receptors that are either absent or present at much lower levels on normal cells.Tumor-targeting peptides from combinatorial libraries Antagonist peptides can target these receptors, such as hormone receptors or PD-L1, to inhibit tumor cell growth and signalingNuclear‐Targeting Peptides for Cancer Therapy - Yi - 2024. Examples of commonly studied peptides include RGD, which targets integrins, and NGR, which targets aminopeptidase N.
* Tumor vasculature: Tumors require a robust blood supply to grow, leading to the overexpression of certain markers on the endothelial cells that form new blood vessels (angiogenesis). Peptides can be designed to target these angiogenic markers, allowing for the delivery of therapies specifically to the tumor's blood supply.
* Tumor microenvironment: The environment surrounding a tumor is distinct from normal tissue and can include specific extracellular matrix components or immune cells. Targeting peptides can be designed to interact with these elements, influencing the tumor microenvironment to enhance drug delivery or modulate the immune response.
Tumor-targeting peptides serve as versatile tools in the fight against cancer, with applications spanning both therapeutic and diagnostic realms.
Therapeutic Applications:
One of the most significant applications is in the targeted delivery of cytotoxic drugs. Peptide-drug conjugates (PDCs) utilize peptide targeting to enhance the delivery of potent drugs directly to tumors.作者：Q Zhang·2023·被引用次数：49—Therefore,targeting peptides based on tumor microenvironmentare very important for tumor-targeted therapy and reducing adverse reactions. Peptide-targeted ... This approach offers advantages such as superior tissue penetration and the ability to deliver higher drug concentrations to the tumor site, potentially leading to improved treatment outcomes.Recent Advancement, Mechanisms of Action ... Beyond direct drug delivery, some peptides can directly modulate the tumor microenvironment or reprogram the immune response, boosting the body's natural ability to recognize and attack cancer cells.作者：K Parang·2026—PDCs utilize peptide targetingto enhance the delivery of potent drugs to tumors, providing advantages such as superior tissue penetration, ... For conditions like glioblastoma, peptides are being explored as a promising therapeutic strategy due to their potential for more effective targeting and reduced side effects.作者：Q Yu·2026—The novel PPC QY-13 exhibits remarkable stability and sustained anticancer durability, which endows it with long-term anticancer potential. In ...
Diagnostic Applications:
In addition to therapeutics, tumor-targeting peptides are invaluable for diagnostic purposes. They can be conjugated to imaging agents (e.作者：M Roveri·2017·被引用次数：57—Peptidescan be designed to selectively bind to such receptors and act astumor-targetingligands, as has been revealed in several preclinical studies.gFull article: Tumor Targeting with Peptide-Drug Conjugates., radionuclides for PET or SPECT imaging) to visualize tumor location, size, and spread. This allows for more accurate diagnosis, staging, and monitoring of treatment response. Numerous peptide-based tumor-imaging agents targeting specific receptors, such as somatostatin receptors, have been developed and utilized in clinical settings.
The development of effective tumor-targeting peptides involves sophisticated design and discovery methodologies. Combinatorial libraries are often employed to screen vast numbers of peptide sequences and identify those with high affinity and specificity for tumor-associated targetsNuclear‐Targeting Peptides for Cancer Therapy - Yi - 2024. Advanced techniques can also be used to screen for peptides with specific binding sites on targets like HER2.2021年8月30日—Numerous peptide-based tumor-imaging agents targeting ssthave been developed over the past decades. Octreoscan® and NeoTect® (technetium-99m- ... Furthermore, researchers are exploring novel classes of molecules, such as proteomimetic polymers (HYDRACs), designed to target and degrade harmful proteins within cancer cells. The design process also considers factors like stability, cell penetration (eIdentification and Characterization of a Suite of Tumor ....g.作者：V Alamdari-palangi·2023·被引用次数：11—Pore-forming peptides, cell-penetrating peptides, and tumor-targeting peptidesare the most common form of molecularly targeted peptides ..., cell-penetrating peptides or CPPs), and the ability to avoid clearance by the body's immune system.Unlocking the potential of tumor-targeting peptides in ...
While the potential of tumor-targeting peptides is immense, several challenges remain.作者：AG Cheetham·2016·被引用次数：38—The advantages thattumor-targeting peptidesoffer over traditional chemotherapy give them significant potential to change the face of a field that currently ... Ensuring broad applicability across different cancer types and patient populations is crucial. Further research is ongoing to optimize peptide stability, enhance their pharmacokinetic properties, and develop more efficient methods for their synthesis and conjugation to therapeutic or diagnostic payloads. The integration of peptide targeting with other advanced modalities, such as nanoparticles and oncolytic viruses, is also a rapidly evolving area, promising even more potent and precise cancer therapies in the future. As research progresses, tumor-targeting peptides are poised to play an increasingly vital role in revolutionizing cancer treatment and improving patient outcomes.Peptides for tumor-specific drug targeting: state of the art ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.